Bank of America Securities Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)
at www.tipranks.com (Tue, 27-Jan 8:28 AM)
Rhythm Pharmaceuticals to Reveal Preliminary Phase 2 Results for Setmelanotide in Prader-Willi Syndrome
Market Chameleon (Thu, 11-Dec 10:31 AM)
Setmelanotide Shows Promising Early Results in Prader-Willi Syndrome: Phase 2 Data Signal Efficacy and Support Advancement
Market Chameleon (Thu, 11-Dec 9:00 AM)
